4.7 Article

Corticotropin-releasing factor 1 receptor mediates the activity of the reward system evoked by morphine-induced conditioned place preference

Journal

NEUROPHARMACOLOGY
Volume 95, Issue -, Pages 168-180

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2014.12.021

Keywords

Morphine; Conditioned place preference; CRF1R; Catecholamine; Orexins; VTA; NAc; NTS-A2; LC; Corticosterone

Funding

  1. Ministerio de Ciencia e Innovacion, Spain [SAF/FEDER2009-07178, SAF/FEDER2010-17907, SAF/FEDER2013-49076-P]
  2. Red de Trastornos Adictivos, Spain [RD12/0028/0003]
  3. Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia Region de Murcia, Spain [15405/PI/10]

Ask authors/readers for more resources

Different neurotransmitter systems are involved in behavioural and molecular responses to morphine. The brain stress system is activated by acute administration of drugs of abuse, being CRF the main neuropeptide of this circuitry. In this study we have studied the role of CRF1R in the rewarding effects of morphine using the CPP paradigm. For that, animals were treated with a CRF1R antagonist (CP-154,526) or vehicle during 6 days. Thirty min after receiving the antagonist, mice were injected with morphine on the same days that CP-154,526 was administered; another group received saline on the same days that vehicle was administered, and both groups were immediately conditioned. Control animals received vehicle and saline every day. On day 7, animals were tested for morphine-induced CPP. c-Fos, TH and OXA immunohistochemistry, NA turnover (HPLC), and corticosterone plasma concentration (RIA) were evaluated. Administration of a CRF1R antagonist CP-154,526 blocked the morphine-induced CPP and the increased NA turnover in the NAc in morphine-paired mice. CP-154-526 antagonised the enhancement in c-Fos expression evoked by morphine-induced CPP in the VIA and NAc, and the activation of the orexinergic neurons in the LLH. Present work demonstrates that morphine-induced CPP activates different brain areas involved in reward, and points out a critical role of CRF1R in molecular changes involved in morphine-conducted behaviours. Thus, our study supports a therapeutic potential of CRF1R antagonists in addictive disorders. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Conditioned aversive memory associated with morphine withdrawal increases brain-derived neurotrophic factor in dentate gyrus and basolateral amygdala

Elena Martinez-Laorden, Javier Navarro-Zaragoza, Maria-Victoria Milanes, Maria-Luisa Laorden, Pilar Almela

ADDICTION BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Cardiac Protective Role of Heat Shock Protein 27 in the Stress Induced by Drugs of Abuse

Elena Martinez-Laorden, Javier Navarro-Zaragoza, Maria Victoria Milanes, Maria Luisa Laorden, Pilar Almela

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Clinical Neurology

Blockade of D3 receptor prevents changes in DAT and D3R expression in the mesolimbic dopaminergic circuit produced by social stress- and cocaine prime-induced reinstatement of cocaine-CPP

Rocio Guerrero-Bautista, Aurelio Franco-Garcia, Juana M. Hidalgo, Francisco Fernandez-Gomez, M. Victoria Milanes, Cristina Nunez

JOURNAL OF PSYCHOPHARMACOLOGY (2020)

Article Clinical Neurology

Unraveling the molecular mechanisms involved in alcohol intake and withdrawal in adolescent mice exposed to alcohol during early life stages

Sandra Montagud-Romero, Lidia Cantacorps, Francisco Jose Fernandez-Gomez, Cristina Nunez, Jose Minarro, Marta Rodriguez-Arias, Maria Victoria Milanes, Olga Valverde

Summary: In mice exposed to alcohol during early development, increased alcohol intake during adolescence was observed, with associated decrease in pCREB/CREB ratio in certain brain areas. Additionally, behavioral alterations such as increased anxiety-like responses during acute alcohol withdrawal and higher blood alcohol concentrations were noted in these early alcohol exposed mice.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)

Article Behavioral Sciences

Naloxone-induced conditioned place aversion score and extinction period are higher in C57BL/6J morphine-dependent mice than in Swiss: Role of HPA axis

Javier Navarro-Zaragoza, E. Martinez-Laorden, F. Javier Teruel-Fernandez, Victoria Gomez-Murcia, Alberto Canovas, Maria-Victoria Milanes, Maria-Luisa Laorden, Pilar Almela

Summary: Our study aimed to investigate the role of the HPA axis in aversive memory expression and extinction in Swiss and B6 mice. We found that B6 mice showed stronger aversive memory and longer extinction times than Swiss mice. Differences in corticosterone levels and responses to a CRF1 receptor antagonist were observed between the two strains, suggesting a strain-specific mechanism in opioid withdrawal memory.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2021)

Article Biochemistry & Molecular Biology

Distinct Regulation of Dopamine D3 Receptor in the Basolateral Amygdala and Dentate Gyrus during the Reinstatement of Cocaine CPP Induced by Drug Priming and Social Stress

Rocio Guerrero-Bautista, Aurelio Franco-Garcia, Juana M. Hidalgo, Francisco Jose Fernandez-Gomez, Bruno Ribeiro Do Couto, M. Victoria Milanes, Cristina Nunez

Summary: Preventing relapse in cocaine addiction is a major challenge in treatment. Cocaine relapse activates memory-related nuclei, affecting emotional and episodic memories. D3 receptor antagonists are emerging as potential treatments for preventing drug relapse.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Molecular Mechanisms Underlying the Retrieval and Extinction of Morphine Withdrawal-Associated Memories in the Basolateral Amygdala and Dentate Gyrus

Aurelio Franco-Garcia, Francisco Jose Fernandez-Gomez, Victoria Gomez-Murcia, Juana M. Hidalgo, M. Victoria Milanes, Cristina Nunez

Summary: This study investigates the molecular mechanisms involved in the retrieval and extinction of morphine withdrawal memories in the basolateral amygdala (BLA) and the hippocampal dentate gyrus (DG) of rats. The results show differential expression and activity of synaptic molecules in these regions during the extinction of aversive memories of opiate withdrawal, providing evidence for the development of therapeutic strategies to minimize relapses induced by morphine withdrawal-associated aversive memories.

BIOMEDICINES (2022)

Editorial Material Neurosciences

Editorial: Unraveling vulnerability factors in addiction drug use and potential treatments

Jorge Montesinos, Sandra Montagud-Romero, Cristina Nunez

FRONTIERS IN NEUROSCIENCE (2022)

Article Medicine, Research & Experimental

Morphine-withdrawal aversive memories and their extinction modulate H4K5 acetylation and Brd4 activation in the rat hippocampus and basolateral amygdala

Aurelio Franco-Garcia, Victoria Gomez-Murcia, Francisco Jose Fernandez-Gomez, Raul Gonzalez-Andreu, Juana M. Hidalgo, M. Victoria Milanes, Cristina Nu Nunez

Summary: Chromatin modification plays a crucial role in various brain processes, including drug addiction. The induction and persistence of drug-induced behavior and molecular changes can be explained by drug-induced epigenetic mechanisms. This study investigated the epigenetic regulation during aversive memory retrieval and extinction in opiate withdrawal, revealing the involvement of histone acetylation and p-Brd4 in these processes.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Article Health Care Sciences & Services

Effect of Pharmaceutical Intervention in Pharmacologically Treated Hypertensive Patients-A Cluster-Randomized Clinical Trial: AFPRES-CLM Study

Raul Luque del Moral, Miguel A. Gastelurrutia, Fernando Martinez-Martinez, Julio A. Jacome, Ana Dago, Blanca Suarez, Narjis Fikri-Benbrahim, Merce Marti, Cristina Nunez, Sandra Sierra-Alarcon, Francisco-Jose Fernandez-Gomez

Summary: Community pharmaceutical intervention can improve blood pressure control in hypertensive patients, improve quality of life, and reduce negative medication-related outcomes and emergency use.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Biochemistry & Molecular Biology

Dopamine D3 Receptor Modulates Akt/mTOR and ERK1/2 Pathways Differently during the Reinstatement of Cocaine-Seeking Behavior Induced by Psychological versus Physiological Stress

Aurelio Franco-Garcia, Rocio Guerrero-Bautista, Juana Maria Hidalgo, Victoria Gomez-Murcia, Maria Victoria Milanes, Cristina Nunez

Summary: Stress triggers relapses in cocaine use, engaging memory-related nuclei, such as BLA and DG. D3 receptor antagonists, like SB-277011-A, reduce cocaine reward and relapse by modulating Akt/mTOR and MEK/ERK1/2 pathways. This study found that SB-277011-A suppressed stress-induced cocaine-seeking behavior and corticosterone enhancement, while also affecting Akt, mTOR, and ERK1/2 activation differently depending on the stressor and dose used.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Meeting Abstract Biochemistry & Molecular Biology

Role of pharmacological antagonism of A2AR in the acquisition of morphine withdrawal-induced CPA

Victoria Gomez-Murcia, Aurelio Franco, Juana Hidalgo, Victoria Milanes, Cristina Nunez Parra

JOURNAL OF NEUROCHEMISTRY (2022)

Correction Neurosciences

'The MK2 cascade regulates mGluR-dependent synaptic plasticity and reversal learning' (vol 155, pg 121, 2019)

Lucia Privitera, Ellen L. Hogg, Matthias Gaestel, Mark J. Wall, Sonia A. L. Correa

NEUROPHARMACOLOGY (2024)

Article Neurosciences

CREB-induced LINC00473 promotes chemoresistance to TMZ in glioblastoma by regulating O6-methylguanine-DNA-methyltransferase expression via CEBPα binding

Li-Ya Jiang, Guan-Hao Wang, Jing-Jiao Xu, Xiao-Li Li, Xiao-Yan Lin, Xiang Fang, Hong-Xu Zhang, Mei Feng, Chun-Ming Jiang

Summary: This study reveals the importance of LINC00473 in regulating temozolomide (TMZ) resistance in glioblastoma (GB) and its potential mechanism. By regulating the expression of CEBP alpha and MGMT, LINC00473 promotes the formation of chemoresistance. Furthermore, LINC00473 can transfer chemoresistance to adjacent sensitive cells through exosomes.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Mitochondrial malfunction mediates impaired cholinergic Ca2+signalling and submandibular salivary gland dysfunction in diabetes

Olga Kopach, Tetyana Pivneva, Nataliya Fedirko, Nana Voitenko

Summary: This study found that diabetic animals exhibit severe xerostomia characterized by reduced saliva flow rate, diminished total protein content, and decreased amylase activity. The impaired saliva production in diabetes is associated with reduced and delayed intracellular Ca2+ signals in submandibular acinar cells, caused by malfunctioning mitochondria. Targeting malfunctioning mitochondria may be a potential strategy for the treatment of diabetic xerostomia.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Non-consummatory behavior signals predict aversion-resistant alcohol drinking in head-fixed mice

Nicholas M. Timme, Cherish E. Ardinger, Seth D. C. Weir, Rachel Zelaya-Escobar, Rachel Kruger, Christopher C. Lapish

Summary: This study aimed to assess aversion-resistant drinking behavior in head-fixed mice and explore the relationship between non-consummatory behaviors and aversion-resistant drinking. The results showed that head-fixed mice exhibited heterogenous levels of aversion-resistant drinking and non-consummatory behaviors were related to the intensity of this behavior.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Daily methocinnamox treatment dose-dependently attenuates fentanyl self-administration in rhesus monkeys

David R. Maguire, Charles P. France

Summary: Methocinnamox (MCAM) is a novel, long-acting opioid receptor antagonist that effectively decreases fentanyl self-administration and prevents opioid overdose in monkeys. The study demonstrates the potential therapeutic utility of MCAM in the treatment of opioid use disorder.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Ventral hippocampus is more sensitive to fluoxetine-induced changes in extracellular 5-HT concentration, membrane 5-HT transporter level and immobility times

Xiang Li, Dan Feng, Shenglu Ma, Mingxing Li, Shulei Zhao, Man Tang

Summary: This study investigated the effects of fluoxetine on neurochemical, neurobiological, and neurobehavioral changes in different subregions of the hippocampus. The results showed that fluoxetine increased dialysate 5-HT, decreased membrane 5-HTT protein, and increased cytoplasmic fraction. Additionally, fluoxetine reduced immobility times in behavioral tests, with greater effects observed in the ventral subregion compared to the dorsal subregion.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Molecular mechanisms of cholinergic neurotransmission in visceral smooth muscles with a focus on receptor-operated TRPC4 channel and impairment of gastrointestinal motility by general anaesthetics and anxiolytics

Alexander V. Zholos, Mariia I. Melnyk, Dariia O. Dryn

Summary: Acetylcholine is an important neurotransmitter in visceral smooth muscles, activating M2 and M3 muscarinic receptors to cause smooth muscle excitation and contraction. This review focuses on the cellular and molecular mechanisms underlying acetylcholine-induced depolarisation and smooth muscle contraction, as well as the effects of anticholinergic drugs on gastrointestinal motility. The knowledge gained from recent studies has greatly expanded our understanding of these processes.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Methylone produces antidepressant-relevant actions and prosocial effects

Zhenlong Li, Hsien-Yu Peng, Chau-Shoun Lee, Tzer-Bin Lin, Ming-Chun Hsieh, Cheng-Yuan Lai, Han-Fang Wu, Lih-Chyang Chen, Mei-Ci Chen, Dylan Chou

Summary: Methylone shows significant efficacy in treating depression and social deficits, making it an ideal candidate for anti-depressant medication.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease

Aline Freyssin, Allison Carles, Sarra Guehairia, Gilles Rubinstenn, Tangui Maurice

Summary: This study explores the potential of combining FENM and S1R agonists in the treatment of Alzheimer's disease. The results showed that most FENM-based combinations can protect against learning deficits caused by A beta 25-35, with better efficacy in short-term memory.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Sex-dependent effect of inflammatory pain on negative affective states is prevented by kappa opioid receptors blockade in the nucleus accumbens shell

J. D. Lorente, J. Cuitavi, L. Rullo, S. Candeletti, P. Romualdi, L. Hipolito

Summary: This study analyzed the effects of pain on negative affect in different sexes and time courses, as well as the involvement of the dynorphinergic and corticotropin releasing factor systems in these pain-related behaviors. The results showed sex and time-dependent anxiety- and anhedonia-like behaviors induced by pain in female rats. The recruitment of KOR/DYN in the NAc was identified as a key neurological substrate mediating pain-induced behavioral alterations.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Intranasal oxytocin alleviates comorbid depressive symptoms in neuropathic pain via elevating hippocampal BDNF production in both female and male mice

Rongjun Liu, Daofan Sun, Xiuzhong Xing, Qingge Chen, Bo Lu, Bo Meng, Hui Yuan, Lan Mo, Liufang Sheng, Jinwei Zheng, Qiusheng Wang, Junping Chen, Xiaowei Chen

Summary: The coexistence of pain and depression is frequently observed in patients with chronic pain and depression. Oxytocin, a neuropeptide, has been reported to relieve chronic pain and depressive symptoms. This study investigated the effect of intranasal oxytocin on neuropathic pain and comorbid depressive symptoms, and found that oxytocin attenuated depression-like behavior but did not alleviate mechanical hyperalgesia. The results suggest that intranasal oxytocin may have the potential to treat depressive symptoms in neuropathic pain patients.

NEUROPHARMACOLOGY (2024)